Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts
Christiane Dings,
Katharina Martha Götz,
Katharina Och,
Iryna Sihinevich,
Quirin Werthner,
Sigrun Smola,
Marc Bliem,
Felix Mahfoud,
Thomas Volk,
Sascha Kreuer,
Jürgen Rissland,
Dominik Selzer,
Thorsten Lehr
Affiliations
Christiane Dings
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Katharina Martha Götz
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Katharina Och
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Iryna Sihinevich
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Quirin Werthner
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Sigrun Smola
Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany
Marc Bliem
CompuGroup Medical (CGM), 56070 Koblenz, Germany
Felix Mahfoud
Department of Internal Medicine III (Cardiology, Angiology, Intensive Care Medicine), Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany
Thomas Volk
Department of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany
Sascha Kreuer
Department of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany
Jürgen Rissland
Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany
Dominik Selzer
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
Thorsten Lehr
Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany
The coronavirus disease 2019 (COVID-19) pandemic challenged many national health care systems, with hospitals reaching capacity limits of intensive care units (ICU). Thus, the estimation of acute local burden of ICUs is critical for appropriate management of health care resources. In this work, we applied non-linear mixed effects modeling to develop an epidemiological SARS-CoV-2 infection model for Germany, with its 16 federal states and 400 districts, that describes infections as well as COVID-19 inpatients, ICU patients with and without mechanical ventilation, recoveries, and fatalities during the first two waves of the pandemic until April 2021. Based on model analyses, covariates influencing the relation between infections and outcomes were explored. Non-pharmaceutical interventions imposed by governments were found to have a major impact on the spreading of SARS-CoV-2. Patient age and sex, the spread of variant B.1.1.7, and the testing strategy (number of tests performed weekly, rate of positive tests) affected the severity and outcome of recorded cases and could reduce the observed unexplained variability between the states. Modeling could reasonably link the discrepancies between fine-grained model simulations of the 400 German districts and the reported number of available ICU beds to coarse-grained COVID-19 patient distribution patterns within German regions.